𝔖 Bobbio Scriptorium
✦   LIBER   ✦

346 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 60 MG AT 48 HOURS INTERVAL ADMINISTERED S.C. TO TREATMENT NAÏVE PATIENTS SUFFERING FROM BPH

✍ Scribed by C. Maclean; F. Larsen; J. Drewe; A.V. Dzmitryieu; A. Gres; A. Strockyi; V. Dovger; A. Ulys; A. Cerniauskienè; P. Geavlete; M. Nikolovski

Book ID
119617678
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
332 KB
Volume
6
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFICACY AND SAFETY OF TEVERELIX LA, A N
EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 30 MG OR 60 MG (SEPARATED BY AT LEAST 12 WEEKS) ADMINISTERED SC TO TREATMENT NAIVE PATIENTS SUFFERING FROM BPH
✍ C.M. Maclean; L. Skillern; F. Larsen; A. Gres; A. Strotski; A.V. Dmitrijev; V.K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB